Thrombosis Research, 1879-2472

Tidskrift

Fler filtreringsmöjligheter
  1. The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism.

    Alaa Alhadad, Massimo Miniati, Hussein Alhadad, Anders Gottsäter & Marika Bajc, 2012, I: Thrombosis Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Retrospective analysis of coagulation parameters at epidural anaesthesia catheter withdrawal after esophageal resection

    P. A. Anveden, L. Preutz, Åsa Rudin, Per Flisberg, E. Eldh & Ulf Schött, 2010, I: Thrombosis Research. 125, Suppl. 2, s. S177-S178

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  3. Uncarboxylated matrix Gla-protein (ucMGP) and osteocalcin (ucOC) increase postoperatively after major abdominal cancer and orthopedic surgery

    P. A. Anveden, Attila Frigyesi, L. Schurgers & Ulf Schött, 2010, I: Thrombosis Research. 125, Suppl. 2, s. S178-S178 1 s.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  4. Immune tolerance induction in patients with hemophilia A

    Jan Astermark, 2011, I: Thrombosis Research. 127, s. S6-S9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Anti- and procoagulant activities in factor VII-deficient subjects

    Jan Astermark, L Tengborn, Ulla Hedner & Erik Berntorp, 2001, I: Thrombosis Research. 101, 6, s. 435-440

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Glycosaminoglycans in cancer treatment.

    Mattias Belting, 2014, I: Thrombosis Research. 133, s. S95-S101

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?

    Maria Berndtsson, Eva Zetterberg, Margareta Holmström, Nida Mahmoud Hourani Soutari, Danijela Mikovic, Ivo Elezovic & Jovan P. Antovic, 2016 aug 1, I: Thrombosis Research. 144, s. 133-135 3 s.

    Forskningsoutput: TidskriftsbidragLetter

  8. Erik von Willebrand.

    Erik Berntorp, 2007, I: Thrombosis Research. 120, s. S3-S4

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. The von Willebrand Disease Prophylaxis Network (vWD PN): Exploring a treatment concept.

    Erik Berntorp & Thomas Abshire, 2006, I: Thrombosis Research. 18, s. S19-S22

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Von Willebrand: The scientist, the disease, the factor, and the treatment

    Erik Berntorp & David Lillicrap, 2007, I: Thrombosis Research. 120, s. S1-S1

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  11. Haemate P/Humate-P: a systematic review.

    Erik Berntorp, 2009, I: Thrombosis Research. 124 Suppl 1, Nov, s. S11-S14

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex.

    Pallonji Bhiladvala, Karin Strandberg, Johan Stenflo & Johan Holm, 2006, I: Thrombosis Research. 118, Aug 10, s. 213-219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Warfarin persistence among stroke patients with atrial fibrillation.

    Fredrik Björck, Henrik Renlund, Peter Svensson & Anders Själander, 2015, I: Thrombosis Research. 136, 4, s. 744-748

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.

    Fredrik Björck, Per Sandén, Henrik Renlund, Peter Svensson & Anders Själander, 2015, I: Thrombosis Research. 136, 2, s. 216-220

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.

    Oscar Braun, Besim Bico, Uzma Chaudhry, Henrik Wagner, Sasha Koul, Patrik Tydén, Fredrik Scherstén, Stefan Jovinge, Peter Svensson, Gustav Smith & Jesper vanderPals, 2015, I: Thrombosis Research. 135, 1, s. 26-30

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. The APC-PCI concentration as an early marker of activation of blood coagulation A study of women on combined oral contraceptives

    K. Bremme, R. Rafik Hamad, Elisabeth Berg, Karin Strandberg & Johan Stenflo, 2012, I: Thrombosis Research. 130, 4, s. 636-639

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD

    G. Castaman, A. Tosetto, A. Cappelletti, A. Goodeve, A. B. Federici, J. Batlle, D. Meyer, J. Goudemand, J. C. J. Eikenboom, R. Schneppenheim, U. Budde, J. Ingerslev, Stefan Lethagen, F. Hill, I. R. Peake & F. Rodeghiero, 2010, I: Thrombosis Research. 126, 3, s. 227-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.

    Roza Chaireti, Rupesh Rajani, Annika Bergquist, Tor Melin, Inga-Lill Friis-Liby, Marjo Kapraali, Stergios Kechagias, Tomas L Lindahl & Sven Almer, 2014, I: Thrombosis Research. 134, 2, s. 455-461

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Treatment with recombinant human erythropoietin induces a moderate rise in hematocrit and thrombin antithrombin in healthy subjects

    Naomi Clyne, Bo Berglund & Nils Egberg, 1995 jul 1, I: Thrombosis Research. 79, 1, s. 125-129 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Effects of hemodialysis and longterm erythropoietin treatment on protein C, and on free and total protein S

    Naomi Clyne, Nils Egberg & Lars Eric Lins, 1995 okt 15, I: Thrombosis Research. 80, 2, s. 161-168 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Targeting exosites of activated protein C as therapeutic possibility?

    Björn Dahlbäck, 2014, I: Thrombosis Research. 133, 6, s. 963-964

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  22. Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis, a prospective multicenter management study.

    J L Elf, Karin Strandberg, Cecilia Nilsson & P J Svensson, 2009, I: Thrombosis Research. May 29, s. 612-616

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. A comprehensive study of ovine haemostasis to assess suitability to model human coagulation

    Samuel R Foley, Connie Solano, Gabriela Simonova, Michelle M Spanevello, Robert J Bird, John W Semple, Denise E Jackson, Andreas Schibler, John F Fraser & Yoke Lin Fung, 2014 aug, I: Thrombosis Research. 134, 2, s. 468-73 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)

    Simona Grasso, Ariane Neumann, Irene M. Lang, Michael Etscheid, Maren von Köckritz-Blickwede & Sandip M. Kanse, 2018, I: Thrombosis Research. 161, s. 36-42 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses

    Bartosz Grzymala-Lubanski, Sara Sjalander, Henrik Renlund, Peter Svensson & Anders Sjalander, 2013, I: Thrombosis Research. 131, 2, s. 130-134

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Mechanical heart valve prosthesis and warfarin - Treatment quality and prognosis.

    Bartosz Grzymala-Lubanski, Ashkan Labaf, Erling Englund, Peter Svensson & Anders Själander, 2014, I: Thrombosis Research. 133, 5, s. 795-798

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Increased thrombin generation in women with a history of preeclampsia

    R. Rafik Hamad, J. Curvers, Erik Berntorp, M. J. Eriksson & K. Bremme, 2009, I: Thrombosis Research. 123, 4, s. 580-586

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Association between variation in ADAMTS13 and aneurysmal subarachnoid hemorrhage

    Ellen Hanson, Sandra Olsson, Bilal Bayazit, Ludvig Z. Csajbok, Karin Nylen, Bengt Nellgård & Christina Jern, 2013, I: Thrombosis Research. 131, 1, s. 99-101

    Forskningsoutput: TidskriftsbidragLetter

  29. History of rFVIIa therapy.

    Ulla Hedner, 2010, I: Thrombosis Research. 125 Suppl 1, s. S4-S6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke.

    Andreas Hillarp, Barbro Palmqvist, Stefan Lethagen, Bruno O Villoutreix & Ingrid Mattiasson, 2003, I: Thrombosis Research. 112, 5-6, s. 275-283

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients

    Line Hjellström & Ashkan Labaf, 2018, I: Thrombosis Research. 163, s. 180-184

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin

    Johan Holm, Andreas Hillarp, Leif RW Erhardt & Erik Berntorp, 1999, I: Thrombosis Research. 96, 3, s. 205-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg

    Lars Holmberg, R Ljung & Inga Marie Nilsson, 1983 jul 1, I: Thrombosis Research. 31, 1, s. 41-50 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Effect on primary haemostasis of prophylactic regimens of low molecular weight heparin, unfractionated heparin, dextran and their combinations. An animal experimental study

    Jan Holst, Bengt Lindblad, Thomas Mätzsch & David Bergqvist, 1992, I: Thrombosis Research. 65, 4-5, s. 651-656

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man

    Jan Holst, Bengt Lindblad, David Bergqvist, Ulla Hedner, Ole Nordfang & Per Ostergaard, 1997, I: Thrombosis Research. 86, 4, s. 343-348

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor

    Jan Holst, Bengt Lindblad, Gertie Westerlund, Claus Bregengaard, Mirella Ezban, Per B. ØStergaard, Ole Nordfang & Ulla Hedner, 1996 feb 15, I: Thrombosis Research. 81, 4, s. 461-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis

    Jan Holst, Bengt Lindblad, Eva Wedeberg, David Bergqvist, Ole Nordfang, Per B. Østergaard & Ulla Hedner, 1993 dec 1, I: Thrombosis Research. 72, 5, s. 467-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Current view and outcome of ITI therapy: A change over time?

    K. Holstein, A. Batorova, M. Carvalho, K. Fijnvandraat, P. Holme, K. Kavakli, T. Lambert, A. Rocino, V. Jiménez-Yuste & J. Astermark, 2016 dec, I: Thrombosis Research. 148, s. 38-44

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study.

    Joseph A Jakubowski, Dominick J Angiolillo, Chunmei Zhou, David S Small, Brian A Moser, Jurrien M Ten Berg, Patricia B Brown, Stefan James, Kenneth J Winters & David Erlinge, 2014, I: Thrombosis Research. 134, 3, s. 552-557

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation

    M. Jansson, S. Själander, V. Sjögren, H. Renlund, B. Norrving & A. Själander, 2020, I: Thrombosis Research. 185, s. 135-141 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters

    Anna Jerkeman, Jan Astermark, Ulla Hedner, Stefan Lethagen, Carl-Gustav Olsson & Erik Berntorp, 2000, I: Thrombosis Research. 98, 6, s. 467-471

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers

    Majid Kalani, Angela Silveira, Margareta Blomback, Jan Apelqvist, Bjorn Eliasson, Jan W. Eriksson, Bengt Fagrell, Ole Torffvit, Anders Hamsten & Gun Jorneskog, 2007, I: Thrombosis Research. 120, 5, s. 653-661

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study

    Gili Kenet, Rolf Ljung, Luminita Rusen, Bryce A Kerlin, Victor Blanchette, Sonata Saulytė Trakymienė, Valentina Uscatescu, Horst Beckmann, Despina Tseneklidou-Stoeter & Nikki Church, 2020 maj, I: Thrombosis Research. 189, s. 96-101 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa